Mabpharm Limited (2181.HK) HKSE

0.61

+0(+0.00%)

Updated at October 15 06:08PM

Currency In HKD

Valuation

Market Cap1.08B
Enterprise Value1.29B
P/E Ratio-84.03
PEG Ratio-1.07
Price/Sales Ratio5.44
Price/Book Ratio23.36
Enterprise/Revenue5.94
Enterprise/EBITDA87.67

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.06
Operating Margin-0.06

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.29

Income Statement

Revenue258.23M
Revenue/Share0.1
Gross Profit219.39M
EBITDA-67.81M
Net Income-127.95M
Diluted EPS-0.03

Balance Sheet

Total Cash94.16M
Total Cash/Share0.02
Total Debt305.01M
Total Debt/Equity3.09
Current Ratio1.07
Book Value Per Share0.02

Price History

52-Week Change69.44
52-Week High0.94
52-Week Low0.25
Moving Average 50 Days0.72
Moving Average 200 Days0.5

Statistics

Average Volume652,582
Shares Outstanding4.12B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A